The Southfield, Mich.-based health system has eight hospitals and nearly $3.5 billion in cash reserves and investments. But, clearly, it's not enough. Beaumont plans to merge with the state's rising star of the industry, Grand Rapids' Spectrum Health, by the fall.
Dr. Georges Benjamin, executive director of the American Public Health Association, joins the Check Up to discuss building confidence in the COVID-19 vaccination effort and how to create local partnerships to encourage people to get their shots.
President Joe Biden’s July 9 executive order included various steps toward making good on campaign promises to take on pharmaceutical companies by allowing the importation of prescription drugs and curbing the high cost of medicines.
If we don't significantly enhance our preparations for cyberattacks now, we risk repeating the disorganized COVID-19 response in early 2020.
As the pandemic continues to take a toll, many businesses are finding it necessary to address worker stress. Given the nature of the services local health-tech startups provide, they are aiming to go above and beyond to help their employees manage their mental health needs.
Noting that nearly all coronavirus deaths now are among the tens of millions of people who haven't received shots, despite widespread vaccine availability, Dr. Vivek Murthy painted an unsettling picture of what the future could hold.
America is awash with vaccine options, and Novavax does not plan to file for regulatory authorizations until late July at the earliest. The delay could have dire consequences for people across the globe awaiting a vaccine.
Pandemic restrictions on Florida-based cruise ships will remain in place after a federal appeals court temporarily blocked a previous ruling that sided with a Florida lawsuit challenging the regulations.
Consolidating less-used facilities, bundling lease negotiations with landlords and grouping complementary services could reduce costs, JLL experts said.
As this $9 billion industry matures, payers should look beyond FDA approval when reviewing the efficacy of digital tools, with a federal imprimatur becoming solely a decision about how to market a product.
